4-185436338-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001114357.3(CFAP96):c.513T>G(p.Asp171Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000839 in 1,549,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001114357.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C4orf47 | ENST00000378850.5 | c.513T>G | p.Asp171Glu | missense_variant | Exon 5 of 8 | 1 | NM_001114357.3 | ENSP00000368127.4 | ||
C4orf47 | ENST00000511581.5 | c.513T>G | p.Asp171Glu | missense_variant | Exon 5 of 5 | 3 | ENSP00000423127.1 | |||
C4orf47 | ENST00000508698.3 | n.*127+155T>G | intron_variant | Intron 3 of 5 | 5 | ENSP00000425418.1 | ||||
C4orf47 | ENST00000511138.5 | c.*28T>G | downstream_gene_variant | 3 | ENSP00000422279.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000195 AC: 3AN: 153952Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 81678
GnomAD4 exome AF: 0.00000859 AC: 12AN: 1397614Hom.: 0 Cov.: 30 AF XY: 0.00000435 AC XY: 3AN XY: 689488
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.513T>G (p.D171E) alteration is located in exon 4 (coding exon 4) of the C4orf47 gene. This alteration results from a T to G substitution at nucleotide position 513, causing the aspartic acid (D) at amino acid position 171 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at